Literature DB >> 17656600

Preoperative diagnosis of insulinoma: low body mass index, young age, and female gender are associated with negative imaging by endoscopic ultrasound.

P H Kann1, D Ivan, A Pfützner, Th Forst, P Langer, S Schaefer.   

Abstract

OBJECTIVE: Endoscopic ultrasound (EUS) is a highly reliable procedure to localize insulinomas preoperatively. It has been considered to be important in planning surgical strategy, especially considering a minimal invasive approach. However, even under ideal conditions experienced examiners miss about 10-20% of insulinomas by EUS imaging. DESIGN AND METHODS: This retrospective study aimed to identify factors associated with negative EUS imaging. Twenty-nine consecutive patients (24 benign and 5 malignant) with sporadic pancreatic insulinomas confirmed by successful surgery and positive histopathology were included. All EUS examinations were performed by one single experienced examiner over a period of one decade.
RESULTS: Three of the tumors were not detected by preoperative EUS as they were isoechoic to the surrounding healthy pancreatic tissue; 25 could be detected as hypoechoic lesions, (including all malignant tumors), and one lesion was hyperechoic. Low body mass index (P=0.053) and young age (P=0.037) were associated with negative EUS imaging. All patients with negative imaging were females. The position on the examiner's learning curve, the diameter and location of insulinoma, and endocrine parameters (insulin concentrations and insulin-glucose ratios in the prolonged fasting test) had no influence on the success of EUS imaging.
CONCLUSIONS: Some insulinomas are missed by preoperative EUS imaging as they are completely isoechoic. A low body mass index, female gender, and young age might be risk factors for negative imaging.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656600     DOI: 10.1530/EJE-07-0117

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

Review 1.  Diagnosis and management of insulinoma.

Authors:  Takehiro Okabayashi; Yasuo Shima; Tatsuaki Sumiyoshi; Akihito Kozuki; Satoshi Ito; Yasuhiro Ogawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 2.  Is endoscopic ultrasonography more sensitive than magnetic resonance imaging in detecting and localizing pancreatic neuroendocrine tumors?

Authors:  Peter Herbert Kann
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

3.  Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) in insulinomas: Indications and clinical relevance in a single investigator cohort of 47 patients.

Authors:  Peter Herbert Kann; Roland Moll; Detlef Bartsch; Andreas Pfützner; Thomas Forst; Gianluca Tamagno; Joachim N Goebel; Verena Fourkiotis; Simona Raluca Bergmann; Maike Collienne
Journal:  Endocrine       Date:  2016-11-30       Impact factor: 3.633

Review 4.  Occult sporadic insulinoma: localization and surgical strategy.

Authors:  Bassam Abboud; Joe Boujaoude
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

5.  Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors.

Authors:  Michelle Kang Kim
Journal:  Gut Liver       Date:  2012-08-07       Impact factor: 4.519

6.  CT during celiac artery angiography for localization of clinically suspected small insulinomas.

Authors:  Feng Duan; Yan-Hua Bai; Li Cui; Jie-Yu Yan; Xiao-Hui Li; Xiu-Qi Wang
Journal:  Cancer Imaging       Date:  2018-06-26       Impact factor: 3.909

7.  Diagnostic value of endoscopic ultrasound for insulinoma localization: A systematic review and meta-analysis.

Authors:  Hao Wang; Ying Ba; Qian Xing; Jian-Ling Du
Journal:  PLoS One       Date:  2018-10-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.